NeuroTechR3 is a Biomedical Device/Digital Health company that develops ML-driven rehabilitation technologies for persons with brain injury.
NeuroTechR3 is a Biomedical Device/Digital Health start-up that develops affordable and versatile rehabilitation technologies for improving upper extremity function in individuals suffering from the effects of brain injury, such as stroke and cerebral palsy. Their innovation, R3THATM, makes personalized telerehabilitation possible by combining machine learning-driven cloud technology with exergames specifically designed to promote neuroplasticity integrating motion tracking, analytics and real-time biofeedback. NeuroTechR3 is dedicated to shifting the rehabilitation industry into a more proactive, patient-centered process by offering solutions for clinicians to balance the demand on efficiency with quality of care to improve patient recovery outcomesThe company, founded 2020 by four women, is a spinout from New Jersey Institute of Technology Biomedical Engineering Department and Rutgers School of Health Professions. It currently has offices at VentureLink@NJIT in Newark, NJ, and at ic@3401 in Philadelphia, PA, and is well positioned in the local market through established relationships with rehabilitation hospitals, out-patient centers, and therapists. The core competence of the company is in using biomedical engineering and computer science to develop its technology. The founders/executive team draws from complementing skills with backgrounds in engineering, software development, digital design, and business development, which allows them to build a data driven, tech savvy, and innovative company with a clear focus on understanding exactly what is happening in our industry to be able to adapt quickly to create sustainable revenue streams.The company’s vision is to change the healthcare system for the better by becoming a disruptor in exergame rehabilitation, expanding this field by providing sustainable and accessible solutions for individuals with all types of impairments. By advancing rehabilitation devices and ML-driven technology, it will have a significant positive impact on people everywhere, contributing to the overall improvement of human health.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jul 25, 2021 | Grant | $20K | 1 | — | — | Detail |
Apr 21, 2021 | Grant | $276K | 1 | National Science Foundation | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Science Foundation | — | Grant |